Argos Therapeutics
develops and commercializes immunotherapy treatments for autoimmune diseases, infectious, cancer and transplantation rejection... Read moreArgos Therapeutics
develops and commercializes immunotherapy treatments for autoimmune diseases, infectious, cancer and transplantation rejection... Read more
CEO
Add
1997
2834 NAICS listing
News
Feb 13, 2019
FiercePharma
Argos Therapeutics: Korean biotechs snatch U.S. stem cell manufacturing facility
Nov 07, 2018
BioPortfolio
Argos Therapeutics: Argos Therapeutics Inc ARGS Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23102018 Prices from USD $250
Aug 21, 2018
BioPortfolio
Argos Therapeutics: Argos Therapeutics Inc ARGS Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12042018 Prices from USD $250
Jul 23, 2018
The Business Journals
Argos Therapeutics: Execs at struggling Argos receive retention pay
Jul 18, 2018
4-traders
Argos Therapeutics: Delisting of Securities of Rosetta Genomics Ltd., ConvergeOne Holdings, Inc. (Warrant Only), FC Global Realty Incorporated, Concordia International Corp., and Argos Therapeutics, Inc. from The Nasdaq Stock Market
Apr 19, 2018
WRAL TechWire
Argos Therapeutics: Argos Therapeutics stock falls 68% as it terminates drug trial
Apr 02, 2018
Market Exclusive
Argos Therapeutics: Argos Therapeutics, Inc. (NASDAQ:ARGS) Files An 8-K Results of Operations and Financial Condition
Apr 02, 2018
Reuters
Argos Therapeutics: BRIEF-Argos Therapeutics Reports Q4 Loss Per Share $0.38
Apr 02, 2018
4-traders
Argos Therapeutics: Argos Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
Mar 28, 2018
Benzinga
Argos Therapeutics: Argos Therapeutics to Report Fourth Quarter and Year-End 2017 Financial Results and Operational Highlights on Monday, April 2, 2018
Argos Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10